Tuberculosis (TB) and human immunodeficiency virus (HIV) Co-Infection brings several
therapeutic challenges. To treat co-infected patients, some key points must be considered …

AIDS complicated with tuberculosis (TB) has become a serious public health problem in
China. The mortality rate of TB/HIV co-infection is higher than that of HIV-negative TB …

Tuberculosis (TB) is a communicable disease that is a major source of illness, one of the ten
causes of mortality worldwide, and the largest cause of death from a single infectious agent …

Tuberculosis (TB) is one of the most important infections affecting HIV-positive patients in the
world. Rates of HIV-related TB have risen in countries in Europe, United States and South …

Combination antiretroviral therapy has revolutionized the care of patients with HIV infection.
The use of two-and three-drug regimens that include agents to inhibit the HIV enzymes …

Tuberculosis (TB) is the most frequent opportunistic infection in patients infected by the
Human immunodeficiency virus (HIV). The mortality related to this co-infection can be …

Since the advent of the AIDS pandemic, tuberculosis (TB) has been recognized as one of
the most important opportunistic infections in HIV-infected individuals. The host …

Tuberculosis (TB) has recently surpassed HIV as the primary infectious disease killer
worldwide, but the two diseases continue to display lethal synergy. The burden of TB is …

The human immunodeficiency virus (HIV) pandemic has amplified the global burden of
tuberculosis (TB), particularly in sub-Saharan Africa, where 82% of the world's TB/HIV …

The vicious interaction between the human immunodeficiency virus (HIV) infection and
tuberculosis (TB) pandemics poses special challenges to national control programs and …